IO Biotech prepares for IPO in the US
IO Biotech, which is based in Copenhagen, has begun the preparations for a listing in the US. Less than a year ago, the biotech company brought in USD 147.2m (DKK 944m) in a series B funding round.
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY DANIEL PEDERSEN
Copenhagen-based biotech company IO Biotech seeks a listing in the US, reports Danish financial daily Børsen, referring to a filing that the firm has sent to the US Securities and Exchange Commission (SEC).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
IO Biotech begins phase III trial with partner MSD
For subscribers
IO Biotech puts down roots in USA and hires new CSO
For subscribers
